A study conducted by researchers based at the St. Jude Children's Research Hospital has determined that healthy lifestyle choices can help cancer survivors avoid the metabolic syndrome.
Patients' relationship with their doctor and their attachment style may affect their physical and mental well-being, especially during vulnerable times such after a cancer diagnosis, according to a new study.
A team of researchers in Canada concludes that combining exercise, nutritional counseling, and symptom control to palliative care from diagnosis helps to improve the quality of life for patients with cancer.
Lung cancer patients could receive more precise treatment, and their progress could be better tracked by using a new high-tech method of non-invasive medical imaging analysis, according to a new study.
Rates of observation as management for low-risk prostate cancer vary widely, and primary ADT is not tied to better survival for men with localized prostate cancer.
Changes in how follicular lymphoma is managed have led to substantial improvement in prognosis and over all survival for patients with the disease.
Scientists have shown that a new drug could prove useful in treating small cell lung cancer, the most aggressive form of lung cancer.
Depressed men with a diagnosis of intermediate- or high-risk prostate cancer have worse overall outcomes.
Physicians who diagnosed low-risk prostate cancer had more influence over the decision to enter active surveillance than did the disease characteristics, according to a case review.
Key genetic variants may affect how cancer patients respond to radiation treatments, according to a new study.
The dietary inflammatory index may be used as a potential predictor of length of hospitalization among patients undergoing surgical treatment of colorectal cancer, according to a team of researchers at Jagiellonian University Medical College, in Krakow, Poland.
The addition of MM-398, a novel nanoliposome formulation of irinotecan, to standard treatment improves survival for metastatic pancreatic cancer patients who have already received gemcitabine.
A new model for paying oncologists reduced cancer care costs by 34% without changing how well patients fared after treatment, according to a study conducted by UnitedHealthcare.
A series of simple telephone calls can make a profound difference in helping women with breast cancer to meet their treatment goals for weight loss.
A new combination of medications for treatment of recurrent ovarian cancer showed improved response rates, increased the rate of tumor shrinkage, and prolonged the time until cancers recurred
A new systematic review shows that treatment with the breast cancer drug trastuzumab is associated with prolonged survival in women with advanced breast cancer, but the risk of developing heart problems also increases.
A new study is suggesting a different approach to treating prostate cancer. Researchers at Comprehensive Cancer Centers of Nevada conducted a study in which 790 men with advanced stages of prostate cancer received early chemotherapy.
New research presents another cause for concern in regard to the chemical bisphenol A (BPA). The study is the first to examine what impact BPA has on the DNA of mammary glands as they age.
Survivors of childhood cancers were hospitalized more often and had longer hospital admissions many years after cancer treatment was completed, compared with the general population.
The earlier a specific phone-based, palliative care support program can be introduced to caregivers, the better they will be able to cope with the caregiving experience, according to research conducted by University of Alabama at Birmingham School of Nursing investigators.
Sometimes the best answer to a patient's question is quiet support. Can you recognize when no words are needed?
A review of studies that evaluated patient-centered outcomes of LDCT screening for lung cancer found that overall quality of life is not significantly impacted in persons who undergo the screening procedure.
A study using a 5-year LDCT screening protocol showed good adherence and patient survival outcomes in persons at high risk of developing lung cancer.
Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent when undergoing lymphoscintigraphy.
Treatment with selumetinib resulted in improved progression-free survival time and tumor response rate compared with chemotherapy, but no improvement was seen in overall survival. Furthermore, the modest improvement in clinical outcomes was accompanied by a high rate of adverse effects.
To better understand breast cancer surgery trends in Canada, researchers reviewed data from the Canadian Institute for Health (CHI) on 57,840 women who underwent breast cancer surgery between 2007 and 2010.
In order to meet new cancer program accreditation standards, institutions have placed new focus on patient navigation, psychosocial distress screening, and survivorship care plans.
A research group's findings demonstrate a role for risk profiling in the interpretation of mammograms. The new approach takes into account a woman's health risk profile, which may reduce both the number of missed cancers and false positives.
A multi-institutional, randomized phase III trial of fractionation in locally advanced head and neck cancer demonstrated improved local-regional control and improved overall survival with no increase in late toxicity with hyperfractionated radiation therapy.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|